Skip to main content
. 2010 Aug 5;29(1):104. doi: 10.1186/1756-9966-29-104

Figure 4.

Figure 4

Resistances of BxPC3 cells to various anti-cancer drugs. BxPC3 cells were incubated with the drugs for 48 hours. Then cell viability was assayed by MTT. Cisplatin showed the strongest anti-tumor ability, with a typical dose-effect curve; gemcitabine showed almost no effect on cellular survival. BPC, Blood peak concentration of drugs.